JP2015529211A5 - - Google Patents

Download PDF

Info

Publication number
JP2015529211A5
JP2015529211A5 JP2015530374A JP2015530374A JP2015529211A5 JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5 JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015530374 A JP2015530374 A JP 2015530374A JP 2015529211 A5 JP2015529211 A5 JP 2015529211A5
Authority
JP
Japan
Prior art keywords
fusion polypeptide
sample
analyte
skp
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015530374A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015529211A (ja
JP6285934B2 (ja
Filing date
Publication date
Priority claimed from EP12006298.9A external-priority patent/EP2706115A1/en
Application filed filed Critical
Publication of JP2015529211A publication Critical patent/JP2015529211A/ja
Publication of JP2015529211A5 publication Critical patent/JP2015529211A5/ja
Application granted granted Critical
Publication of JP6285934B2 publication Critical patent/JP6285934B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015530374A 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド Active JP6285934B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12006298.9 2012-09-06
EP12006298.9A EP2706115A1 (en) 2012-09-06 2012-09-06 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays
PCT/EP2013/068269 WO2014037389A1 (en) 2012-09-06 2013-09-04 Chaperone-chaperone fusion polypeptides for reduction of interference and stabilization of immunoassays

Publications (3)

Publication Number Publication Date
JP2015529211A JP2015529211A (ja) 2015-10-05
JP2015529211A5 true JP2015529211A5 (enExample) 2016-09-15
JP6285934B2 JP6285934B2 (ja) 2018-02-28

Family

ID=46963361

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015530374A Active JP6285934B2 (ja) 2012-09-06 2013-09-04 イムノアッセイの干渉の低減、及び安定化のためのシャペロン−シャペロン融合ポリペプチド

Country Status (6)

Country Link
US (1) US10197559B2 (enExample)
EP (2) EP2706115A1 (enExample)
JP (1) JP6285934B2 (enExample)
CN (1) CN104583408B (enExample)
CA (1) CA2881411C (enExample)
WO (1) WO2014037389A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112018017336A2 (pt) * 2016-03-07 2018-12-26 Hoffmann La Roche método in vitro para detectar um anticorpo para p53 (anticorpo anti-p53) em uma amostra e polipeptídeo de fusão
JP7389740B2 (ja) * 2017-07-27 2023-11-30 エフ. ホフマン-ラ ロシュ アーゲー Hcv抗原のマルチエピトープ融合タンパク質およびその使用
CA3076337A1 (en) 2017-09-19 2019-03-28 Massachusetts Institute Of Technology Compositions for chimeric antigen receptor t cell therapy and uses thereof
CN115843334B (zh) 2020-04-23 2026-01-13 豪夫迈·罗氏有限公司 用于抗体免疫测定的冠状核衣壳抗原
WO2023213758A1 (en) 2022-05-03 2023-11-09 F. Hoffmann-La Roche Ag Hiv gp41 variants for immunodiagnostic assays
CN122138968A (zh) 2023-11-09 2026-06-02 罗氏诊断公司 用于标记的转谷氨酰胺酶底物
WO2026027625A1 (en) 2024-07-31 2026-02-05 Roche Diagnostics Gmbh Hepatitis delta virus polypeptides and detection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE522603T1 (de) 2001-06-22 2011-09-15 Hoffmann La Roche Löslicher komplex, der retrovirale oberflächen- glykoproteine und fkpa oder slyd enthält
JP4871960B2 (ja) * 2006-01-03 2012-02-08 エフ.ホフマン−ラ ロシュ アーゲー 優れたシャペロン活性およびフォールディング活性を有するキメラ融合タンパク質
ATE516298T1 (de) 2007-04-20 2011-07-15 Hoffmann La Roche Erkennung von primären infektionen mit krankheitserregern
CN101939330B (zh) 2007-12-13 2014-06-04 霍夫曼-拉罗奇有限公司 新型风疹e1包膜蛋白变体及其在检测抗风疹抗体中的用途
EP2127678A1 (en) * 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology

Similar Documents

Publication Publication Date Title
EP4582812A3 (en) Assays for detecting the presence or amount of an anti-drug antibody
MX362075B (es) Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
ZA202002415B (en) Detection of symmetrical dimethylarginine
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
JO3812B1 (ar) أجسام مضادة ترتبط بالمركب الترابطي البشري للموت المبرمج 1 (pd-l1)
JP2009284902A5 (enExample)
BR112015022844A2 (pt) métodos para detecção de anticorpos para doadores específicos e sistemas para pratica destes
Ngubane et al. High-throughput sequencing enhanced phage display identifies peptides that bind mycobacteria
JP2015527365A5 (enExample)
JP2017536846A5 (enExample)
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
MX353464B (es) Antigenos tpn47 de treponema pallidum, inmunoreactivos, solubles.
JP2016528486A5 (enExample)
JP2013174612A5 (enExample)
Kim et al. Dual synergistic response for the electrochemical detection of H1N1 virus and viral proteins using high affinity peptide receptors
Kim et al. A one-step immunoassay based on switching peptides for diagnosis of porcine epidemic diarrhea virus (PEDV) using screened Fv-antibodies
WO2015128394A3 (en) Soluble and immunoreactive variants of htlv capsid antigen p24
WO2018068064A3 (en) Mycobacterium tuberculosis proteins in diagnostic assays and devices for tuberculosis detection and diagnosis
JP2017512200A5 (enExample)
JP2014524583A5 (enExample)
JP2017037014A5 (enExample)
JP2013186124A5 (enExample)
JP2017533913A5 (enExample)
JP2017524921A5 (enExample)